We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Most cancer tissues showed weak to moderate nuclear immunoreactivity. Most head and neck cancers along with few melanomas, cervical, lung, colon and stomach cancers were strongly stained. Carcinoid, glioma, lymphoma, liver, prostate, thyroid and renal cancers were mostly negative
Cancer tissues showed moderate to strong nuclear immunoreactivity in a fraction of cells. Several tumor types were weakly stained or negative, for example melanomas, prostate and renal cancers.
GENE INFORMATION
Gene name
SKP2 (HGNC Symbol)
Synonyms
FBL1, FBXL1, p45
Description
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase (HGNC Symbol)
Entrez gene summary
This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbls class; in addition to an F-box, this protein contains 10 tandem leucine-rich repeats. This protein is an essential element of the cyclin A-CDK2 S-phase kinase. It specifically recognizes phosphorylated cyclin-dependent kinase inhibitor 1B (CDKN1B, also referred to as p27 or KIP1) predominantly in S phase and interacts with S-phase kinase-associated protein 1 (SKP1 or p19). In addition, this gene is established as a protooncogene causally involved in the pathogenesis of lymphomas. Alternative splicing of this gene generates three transcript variants encoding different isoforms. [provided by RefSeq, Jul 2011]
Q13309 [Direct mapping] S-phase kinase-associated protein 2
Show all
Phobius predicted membrane proteins Predicted intracellular proteins Cancer-related genes Candidate cancer biomarkers Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Q13309 [Direct mapping] S-phase kinase-associated protein 2 A0A024R069 [Target identity:100%; Query identity:100%] S-phase kinase-associated protein 2 (P45), isoform CRA_c
Show all
Predicted intracellular proteins Cancer-related genes Candidate cancer biomarkers Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000082 [G1/S transition of mitotic cell cycle] GO:0000086 [G2/M transition of mitotic cell cycle] GO:0000209 [protein polyubiquitination] GO:0000278 [mitotic cell cycle] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005730 [nucleolus] GO:0005737 [cytoplasm] GO:0005829 [cytosol] GO:0006511 [ubiquitin-dependent protein catabolic process] GO:0008283 [cell proliferation] GO:0016235 [aggresome] GO:0016567 [protein ubiquitination] GO:0019005 [SCF ubiquitin ligase complex] GO:0031145 [anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process] GO:0031146 [SCF-dependent proteasomal ubiquitin-dependent protein catabolic process] GO:0033148 [positive regulation of intracellular estrogen receptor signaling pathway] GO:0042802 [identical protein binding] GO:0042981 [regulation of apoptotic process] GO:0048661 [positive regulation of smooth muscle cell proliferation] GO:0051726 [regulation of cell cycle] GO:0061630 [ubiquitin protein ligase activity] GO:0071460 [cellular response to cell-matrix adhesion] GO:1902916 [positive regulation of protein polyubiquitination]